STAT3 and neoplasm: Although poly(ADP-ribose) polymerase inhibition shows efficacy in BRCA-mutated OC, it concurrently upregulates STAT3 signaling in tumor cells, inducing pro-tumor TAM polarization and ultimately driving therapy resistance [121].